Quantcast

Latest Pharmaceuticals policy Stories

2014-09-18 08:28:42

OTTAWA, Sept. 18, 2014 /CNW/ - A new expert panel report, Improving Medicines for Children in Canada, released today by the Council of Canadian Academies, addresses the importance of developing safe and effective medicines for children. Each year about half of Canada's seven million children use at least one prescription drug. Much of this prescribing is done off-label (i.e. the prescription differs from the authorized use), creating potential health risks. Children have historically been...

2014-09-17 23:06:51

Analysts interviewed for the Sept. 12 issue of Atlantic Information Services’s Drug Benefit News agree that despite concerns, the strategy is here to stay. Washington, DC (PRWEB) September 17, 2014 In ongoing coverage of formulary exclusion lists, Atlantic Information Services, Inc.’s Drug Benefit News (DBN) continues to find criticism surrounding the tactic. As first reported in its Aug. 8 issue, CVS Caremark Corp. and Express Scripts Holding Co.’s formulary exclusion lists for...

2014-09-17 20:22:10

OTTAWA, Sept. 17, 2014 /CNW/ - Health Canada has taken the precautionary step of asking IPCA Laboratories in India to voluntarily stop shipment of products to Canada based on a review of a recent good manufacturing practices (GMP) inspection report by the U.S. Food and Drug Administration (FDA) where they identified falsification and manipulation of data issues at the company. IPCA has not disputed the FDA findings with Health Canada. The FDA has not issued a recall of any of the...

2014-09-17 12:27:16

DALLAS, Sept. 17, 2014 /PRNewswire-iReach/ -- The abuse of prescription pain medication is the deadliest drug problem facing America, according to a study by the Centers for Disease Control and Prevention (CDC). The CDC reports prescription drugs have a higher overdose rate than heroin and cocaine combined. Physicians are now taking a harder look at their role in this national epidemic and doing something about it by using a new non-narcotic alternative for pain relief after surgery....

2014-09-17 08:31:00

HAYWARD, Calif., Sept. 17, 2014 /PRNewswire/ -- Impax Pharmaceuticals, the branded products division of Impax Laboratories, Inc. (NASDAQ: IPXL) today announced that the U.S. Food and Drug Administration (FDA) has extended the Prescription Drug User Fee Act (PDUFA) date for its review of the RYTARY(TM) (IPX066) New Drug Application (NDA) from October 9, 2014, to January 9, 2015. The Company amended the chemical, manufacturing and control (CMC) section of the RYTARY NDA subsequent to...

2014-09-17 04:21:26

GLASGOW, Scotland, September 17, 2014 /PRNewswire/ -- First antibacterial with a new mode of action from a truly novel class of anti-infective in over a decade MGB Biopharma, a biopharmaceutical company developing a truly novel class of anti-infectives, announces today that it has secured GBP4.0m ($6.4m) to advance the development of its lead antibacterial, MGB-BP-3, against a range of Gram-positive infections including Clostridium...

2014-09-16 12:30:26

BOSTON, September 16, 2014 /PRNewswire/ -- Russia's pharmaceutical market has been growing faster over recent years. The Pharma 2020 Strategy provides incentives for local producers to develop original and generic drugs for both domestic and foreign markets. These trends, however, were affected by recent developments connected with the political situation and the following political and economic sanctions imposed on Russia. (Logo:...

2014-09-16 08:29:33

ALPINE, UT, Sept. 16, 2014 /PRNewswire/ - American Biotech Labs, LLC, is pleased to announce the availability of three new silver hydrogel wound-dressing products. The new products will allow American Biotech Labs (ABL) to market in the wound-care market focusing on ultimate sports and fitness, spa and health, and animal markets. The new over-the-counter (OTC) products will have wound-dressing claims for minor cuts, lacerations, abrasions, 1st and 2nd degree burns, and skin...

2014-09-15 16:29:09

SAN DIEGO, Sept. 15, 2014 /PRNewswire/ -- Cannalink, Inc. (OTC Pink Sheets: SUPID) (the "Company"), formerly Superwire, Inc., announces that it has effected a change of name of the Company from Superwire, Inc. to Cannalink, Inc. and a 1 for 50 reverse split. The two corporate actions were approved by FINRA effective September 10, 2014. The Company maintains its headquarters in San Diego, California and is managed by its new Chairman and Chief Executive Officer, Robert L. Plomgren....

2014-09-15 00:20:19

SAN DIEGO, Sept. 14, 2014 /PRNewswire/ -- HUYA Bioscience International (HUYA), a leader in accelerating the global development of China's pharmaceutical innovations, today announced a joint venture with Tianjin Institute of Pharmaceutical Research (TIPR) to develop medical technologies and therapies, originating in both China and the western world, for global markets. Under the terms of the joint venture, to be known as TIPR-HUYA Advancing Innovative Medicines (TIPR-HUYA-AIM), HUYA...


Word of the Day
omphalos
  • The navel or umbilicus.
  • In Greek archaeology: A central boss, as on a shield, a bowl, etc.
  • A sacred stone in the temple of Apollo at Delphi, believed by the Greeks to mark the 'navel' or exact center-point of the earth.
'Omphalos' comes from the ancient Greek.
Related